| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |